A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of
risperidone long-acting injection (LAI) versus oral antipsychotics in participants with
recent onset psychosis (abnormal thinking and/or hallucinations).